Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027. Novo Nordisk's blockbuster diabetes drug ...

President Donald Trump said he plans to order a cut in US prescription drug costs by mandating that Americans pay no more ...

In 2023, Medicare selected 10 drugs for its first round of price negotiations. Agreements were reached with drug manufacturers to establish new, reduced prices for all 10 drugs. These prices ...

Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug manufacturers ...

The executive order was the largest action to date by the second Trump administration on prescription drug costs but experts ...

The order Trump is promising will direct the Department of Health and Human Services to tie what Medicare pays for ...

Likewise, the order calls to match the Medicare payment for certain prescription drugs to the price that hospitals ... on the pharmaceutical sector were headed down the pipeline.

Such a change has the potential to increase costs for the government, because it would most likely delay the existing timetable for some drugs to become eligible for Medicare price cuts.

Kennedy Jr. to provide the President with guidance on reform to the Medicare Drug Price Negotiation ... US states to import drugs from Canada. Despite sweeping staff cuts seen in recent weeks ...